Galderma Receives European Union Approval for Restylane® Shaype™: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection ...
FierceBiotech

Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection

SCOTTSDALE, Ariz., Feb. 10 /PRNewswire/ -- Recent clinical data show that Restylane(R) lasted 18 months in 97% of patients with one repeat injection. Restylane(R) is the only HA filler with an ...
PopSugar

What to Know About Restylane Eyelight, the FDA-Approved Filler For the Undereye Area

If the eyes are the window to the soul, the undereye area is the couch on which all of the soul's stresses like to lounge. Also called the tear trough, the undereye area can sometimes be a pretty good ...

Galderma Receives European Union Approval for Restylane Shaype: the First-and-Only Bone-Mimicking Hyaluronic Acid Injectable for Facial Shaping

Galderma has introduced the first-and-only shaper to the hyaluronic acid (HA) market with Restylane Shaype, now approved in the European Union (EU) for chin augmentation1 Restylane Shaype is ...